SAB Biotherapeutics, Inc. (SABS)
3.99
+0.04
(+1.01%)
USD |
NASDAQ |
Dec 19, 16:00
3.96
-0.03
(-0.75%)
Pre-Market: 20:00
SAB Biotherapeutics Market Cap: 189.95M for Dec. 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 14.90M |
| AIM ImmunoTech, Inc. | 1.085M |
| IGC Pharma, Inc. | 27.86M |
| NovaBay Pharmaceuticals, Inc. | 667.86M |
| Protalix Biotherapeutics, Inc. | 139.13M |
Market Cap Related Metrics
| PS Ratio | 919.50 |
| Price to Book Value | 1.151 |
| Price | 3.99 |
| Earnings Yield | -77.39% |